Case Report: Valproic Acid and Risperidone Treatment Leading to Development of Hyperammonemia and Mania

Autor/inn/en	Carlson, Teri; Reynolds, Charles A.; Caplan, Rochelle
Titel	Case Report: Valproic Acid and Risperidone Treatment Leading to Development of Hyperammonemia and Mania
Quelle	In: Journal of the American Academy of Child & Adolescent Psychiatry, 46 (2007) 3, S.356 (6 Seiten) PDF als Volltext Verfügbarkeit
Sprache	englisch
Dokumenttyp	gedruckt; online; Zeitschriftenaufsatz
ISSN	0890-8567
Schlagwörter	Drug Therapy; Symptoms (Individual Disorders); Children; Psychiatry; Behavior Problems; Pharmacology; Asperger Syndrome; Aggression; Attention Deficit Disorders; Hyperactivity; Case Studies; Males; Psychosis + Suchen Sie Ihr Suchwort? Psychiatrische Symptomatik; Child; Kind; Kinder; Psychiatrie; Arzneikunde; Asperger-Syndrom; Attention deficit hyperactivity disorder; ADHS; Aufmerksamkeits-Defizit-Hyperaktivitäts-Störung; Aufmerksamkeitsstörung; Hyperaktivität; Case study; Fallstudie; Case Study; Male; Männliches Geschlecht; Psychose
Abstract	This case report describes two children who developed hyperammonemia together with frank manic behavior during treatment with a combination of valproic acid and risperidone. One child had been maintained on valproic acid for years and risperidone was added. In the second case, valproic acid was introduced to a child who had been treated with risperidone for years. In both cases, discontinuing the valproic acid resulted in normalization of ammonia levels and cessation of the manic behavior. This case report alerts physicians to the importance of obtaining serum ammonia levels in children treated with valproic acid and risperidone who present with manic behavior. (Author).
Anmerkungen	Lippincott Williams & Wilkins. P.O. Box 1600, Hagerstown, MD 21741. Tel: 800-638-3030; Tel: 301-223-2300; Fax: 301-223-2400; Web site: http://www.lww.com/product/?0890-8567
Erfasst von	ERIC (Education Resources Information Center), Washington, DC
Update	2017/4/10